---
title: "SC Pharmaceuticals (002693.SZ) — Financial Reports"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/002693.SZ/norm.md"
symbol: "002693.SZ"
name: "SC Pharmaceuticals"
parent: "https://longbridge.com/en/quote/002693.SZ.md"
datetime: "2026-06-25T06:04:29.007Z"
locales:
  - [en](https://longbridge.com/en/quote/002693.SZ/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/002693.SZ/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/002693.SZ/norm.md)
---

# SC Pharmaceuticals (002693.SZ) — Financial Reports

## Income Statement (CNY)

| Indicator | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| EPS | 0.0083 | 0.0764 | 0.0388 | -0.0203 | -0.0242 |
| ROE | 3.33% | 21.48% | 16.65% | -8.89% | -10.34% |
| Revenue | 48.44M | 107.86M | 84.78M | 47.45M | 36.68M |
| Net income | 3.45M | 21.57M | 15.94M | -8.43M | -10.04M |
| Operating income | 3.35M | 21.01M | 15.03M | -7.38M | -11.30M |
| Gross margin | 62.35% | 44.89% | 69.99% | 38.50% | 49.57% |
| Net margin | 7.12% | 20.00% | 18.80% | -17.76% | -27.38% |
| Profit quality | 16.60% | 72.76% | 44.64% | -227.37% | - |

## Balance Sheet (CNY)

| Indicator | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| A&L | 816.14M | 825.78M | 797.77M | 754.38M | 762.22M |
| Leverage | 1.94 | 1.96 | 1.97 | 1.94 | 1.91 |
| BVPS | 1.00 | 0.9946 | 0.9426 | 0.9042 | 0.9245 |
| Turnover | 0.3656 | 0.3439 | 0.2665 | 0.2076 | 0.2154 |
| Cash & STI | 74.14M | 59.10M | 54.92M | 19.05M | 33.22M |
| Inv & Rec | 71.16M | 66.09M | 85.66M | 79.55M | 76.60M |
| LT assets | 400.59M | 399.69M | 397.10M | 403.99M | 410.64M |
| Net debt | 220.29M | 221.64M | 236.01M | 251.68M | 252.81M |

## Cash Flow Statement (CNY)

| Indicator | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| Operating CF | 20.19M | 28.87M | 33.67M | 3.25M | -4.84M |
| Investing CF | -19.02M | 9.46M | -21.61M | 6.99M | -36.78M |
| Financing CF | 6.19M | -7.74M | 11.81M | -9.05M | -147635.00 |
| Free CF | -12.50M | 51.84M | -27.95M | 18.57M | -24.72M |
| OCF coverage | 140.13% | 75.63% | 249.42% | 13.99% | -43.92% |
| Repaid & issued | 10.00M | 18.49M | 10.51M | 8.49M | - |
| CapEx | -10.60M | -17.00M | -9.74M | -9.37M | -7.15M |